Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

By S. Al-Batran, J. Hartmann, S. Probst, H. Schmalenberg, S. Hollerbach, R. Hofheinz, V. Rethwisch, G. Seipelt, N. Homann, G. Wilhelm and 10 more. Journal of Clinical Oncology, 2008

757 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/42019a209953f1e9267159a3706c79ba7bc7c45b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Nordlinger
2. W. Bechstein
3. K. Ott
4. E. Van Cutsem
5. M. Lutz
6. P. Reichardt
7. H. Wilke
8. M. Mauer

Citations in the corpus

• Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. (2010, background): “Other less toxic but similarly active oxaliplatinbased regimens might be better suited for this patient population.(20) In designing a future trial, investigators may incorporate lessons learned in this trial: stage as accurately as possible including laparoscopy and adequate D2-lymph node dissectio”